Passage Bio Receives European Commission Orphan Designation for PBKR03 for Treatment of …,

“We are planning to initiate in the first half of this year our clinical trial program, GALax-C, to study PBKR03 as a treatment for early infantile Krabbe …, “We are planning to initiate in the first half of this year our clinical trial program, GALax-C, to study PBKR03 as a treatment for early infantile Krabbe …, Read More